PubRank

Li-Bing Song

Author PubWeight™ 33.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008 3.04
2 Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 2011 1.75
3 Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 2009 1.59
4 Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Res 2007 1.56
5 Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol 2009 1.54
6 High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis. PLoS One 2012 1.43
7 Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 2008 1.40
8 Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010 1.40
9 Bmi-1 expression predicts prognosis for patients with gastric carcinoma. J Surg Oncol 2008 1.31
10 Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 2005 1.30
11 Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer 2009 1.26
12 Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Cancer 2009 1.23
13 Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2008 1.16
14 Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Clin Cancer Res 2007 1.13
15 GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med 2012 1.12
16 High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma. PLoS One 2013 1.08
17 Flotillin-2 is associated with breast cancer progression and poor survival outcomes. J Transl Med 2013 1.04
18 Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. J Transl Med 2011 0.97
19 Prognostic relevance of Centromere protein H expression in esophageal carcinoma. BMC Cancer 2008 0.94
20 Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in Nasopharyngeal Carcinoma via activation of NF-κB pathway. Mol Cancer 2014 0.92
21 Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma. Biochem Biophys Res Commun 2008 0.87
22 High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer. BMC Gastroenterol 2013 0.85
23 Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression. J Exp Clin Cancer Res 2009 0.84
24 Proteasome inhibitor MG-132 modifies coxsackie and adenovirus receptor expression in colon cancer cell line lovo. Cell Cycle 2008 0.82
25 [Identification of differentially expressed genes in primary cultured nasopharyngeal carcinoma cells by cDNA microarray]. Nan Fang Yi Ke Da Xue Xue Bao 2007 0.82
26 [Expression and significance of Bmi-1 in breast cancer]. Ai Zheng 2007 0.81
27 Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival. Chin J Cancer 2011 0.80
28 [Expression and clinical significance of DNA-PKcs in nasopharyngeal carcinoma]. Ai Zheng 2008 0.80
29 [Establishment of three-dimensional culture models related to different stages of nasopharyngeal carcinogenesis]. Ai Zheng 2005 0.78